高级搜索
非小细胞肺癌中VEGF-C 的表达及其与淋巴血道转移和预后之间的关系[J]. 肿瘤防治研究, 2005, 32(11): 705-707. DOI: 10.3971/j.issn.1000-8578.2214
引用本文: 非小细胞肺癌中VEGF-C 的表达及其与淋巴血道转移和预后之间的关系[J]. 肿瘤防治研究, 2005, 32(11): 705-707. DOI: 10.3971/j.issn.1000-8578.2214
The Expression of VEGF-C in Non-small-cell-lung Cancer and Its Relationship with Lympha Node Metastasis, Hematogenous Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2005, 32(11): 705-707. DOI: 10.3971/j.issn.1000-8578.2214
Citation: The Expression of VEGF-C in Non-small-cell-lung Cancer and Its Relationship with Lympha Node Metastasis, Hematogenous Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2005, 32(11): 705-707. DOI: 10.3971/j.issn.1000-8578.2214

非小细胞肺癌中VEGF-C 的表达及其与淋巴血道转移和预后之间的关系

The Expression of VEGF-C in Non-small-cell-lung Cancer and Its Relationship with Lympha Node Metastasis, Hematogenous Metastasis and Prognosis

  • 摘要: 目的 探讨血管内皮生长因子一c在肺癌组织中的表达及其与肺癌淋巴血道转移和预后的关系。方法 回顾性分析43例术前未进行化疗和放疗的肺癌病人的切除标本,采用免疫组化SP法检测肺癌组织中的VEGF-C的表达。结果 肺鳞癌中VEGF-C的阳性表达率62.5%(15/24),腺癌中VEGF-C的阳性表达率为68.24%(13/19);VEGF-C的阳性表达与淋巴结的转移,肺癌的病理分期以及手术后血性转移显著相关(P=0.01),VEGF-C阳性表达的3年生存率为23.43%,5年生存率为18.75%,阴性表达的3年生存率为60.71%,5年生存率为59.82%,两者之间差异显著(P〈0.05)。结论 VEGF-C对于肺癌的侵袭、淋巴结转移、手术后血性转移以及预后有一定作用。

     

    Abstract: Objective  The objective of this study is to detect the expression of VEGF-C in Non-Small Cell Lung Cancer, and to explore their association with invasion lymph metastasis hemagenous metastasis and prognosis. Methods  A rapid immunohistochemical method ( streptoavidin-peroxidase SP) was used to detect VEGF-C proteins expression in 43 cases of Non-Small Cell Lung Carcinoma, these cases were not treated radiotherapy or chemotherapy before operation. Results  The expression rates of VEGF-C in lung squamous cell carcinoma and lung adenoccarcinoma were 54. 16 %, 84. 21 % respectively. The positive expression of VEGF-C were significantly correlated with lympha node metastasis, TNM stage and postoperative hematogenous metastasis ( P = 0. 01) The 32year, 52year survival rates of VEGF-C positive groups were 24. 43 %, 18. 75 %, The 32 year 52 year survival rates of VEGF-C negative expression groups were 64. 71 %, 58. 82 %, There were significant difference of survival time between VEGF2C positive expression and VEGF-C negative expression groups ( P < 0. 05) . Conclusion  VEGF-C may play a role in invasion, lympha node metastasis, postoperative hematogenous metastasis and prognosis.

     

/

返回文章
返回